GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (LTS:0G5I) » Definitions » EBIT

Prolight Diagnostics AB (LTS:0G5I) EBIT : kr-26.68 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Prolight Diagnostics AB EBIT?

Prolight Diagnostics AB's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was kr2.08 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-26.68 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Prolight Diagnostics AB's annualized ROC % for the quarter that ended in Dec. 2024 was 3.98%. Prolight Diagnostics AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 126.07%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Prolight Diagnostics AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -5.45%.


Prolight Diagnostics AB EBIT Historical Data

The historical data trend for Prolight Diagnostics AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB EBIT Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only -4.17 -6.86 - -135.27 -26.68

Prolight Diagnostics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -110.04 -8.87 -11.16 -8.73 2.08

Competitive Comparison of Prolight Diagnostics AB's EBIT

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's EV-to-EBIT falls into.


';

Prolight Diagnostics AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-26.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB  (LTS:0G5I) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Prolight Diagnostics AB's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=5.984 * ( 1 - 0% )/( (147.657 + 152.681)/ 2 )
=5.984/150.169
=3.98 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Prolight Diagnostics AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=8.3/( ( (6.67 + max(-19.524, 0)) + (6.497 + max(-20.252, 0)) )/ 2 )
=8.3/( ( 6.67 + 6.497 )/ 2 )
=8.3/6.5835
=126.07 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.004999999999999) - (3.839 + 0 + 15.69)
=-19.524

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.0030000000000037) - (3.785 + 0 + 16.47)
=-20.252

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Prolight Diagnostics AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-26.682/489.770
=-5.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB EBIT Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB Business Description

Traded in Other Exchanges
Address
Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.

Prolight Diagnostics AB Headlines

No Headlines